{"timestamp": 1771603726.6587915, "value": {"ticker": "NMRA", "company_name": "Neumora Therapeutics, Inc.", "short_name": "Neumora Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 576091328, "float_shares": 90973339, "shares_outstanding": 169938441, "short_ratio": 2.51, "short_percent_of_float": 0.0844, "shares_short": 5634962, "shares_short_prior": 7502647, "insider_percent_held": 0.26829, "institution_percent_held": 0.60553, "total_cash": 171524992, "total_debt": 20086000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 15.198, "current_ratio": 6.852, "book_value": 0.816, "price_to_book": 4.154412, "operating_cashflow": -208824992, "free_cashflow": -120069128, "price": 3.39, "52w_high": 3.4886, "52w_low": 0.611, "avg_volume": 1680626, "avg_volume_10d": 2388950, "full_time_employees": 95, "audit_risk": 0, "overall_risk": 0}}